Screener
Lexicon Pharmaceuticals LXRX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 27,232 | 25,130 | 49,330 | 52,071 |
| (Loss) income from operations | (26,540) | 3,736 | (27,536) | (21,943) |
| Interest and other expense | (2,609) | (2,318) | (4,199) | (4,153) |
| Interest and other income | 1,723 | 1,834 | 3,266 | 4,053 |
| Loss on early extinguishment of debt | (4,349) | — | (4,349) | — |
| Net (loss) income | $(31,775) | $3,252 | $(32,818) | $(22,043) |
| Net (loss) income per common share, basic | $(0.07) | $0.01 | $(0.08) | $(0.06) |
| Net (loss) income per common share, diluted | $(0.07) | $0.01 | $(0.08) | $(0.06) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's other income (expense)?
- Lexicon Pharmaceuticals (LXRX) reported other income (expense) of $1.72M in Q2 2026.
- How has Lexicon Pharmaceuticals's other income (expense) changed year-over-year?
- Lexicon Pharmaceuticals's other income (expense) decreased by 6.1% year-over-year, from $1.83M to $1.72M.
- What is the long-term trend for Lexicon Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's other income (expense) has grown at a 167.9% compound annual growth rate (CAGR), from $134K to $6.91M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Lexicon Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude